Cellink Relaunches a Real-Time qPCR Instrument for Covid-19
Quantitative real-time PCR is proven technology with diagnostic and research applications, including the quantification and genotyping of human pathogens such as SARS-CoV-2.
Read MorePosted by | Apr 2, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Quantitative real-time PCR is proven technology with diagnostic and research applications, including the quantification and genotyping of human pathogens such as SARS-CoV-2.
Read MorePosted by | Apr 2, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases, Molecular Diagnostics |
Vela Diagnostics will offer the manual ViroKey SARS-CoV-2 RT-PCR test when validation is completed, which is targeted for early April 2020.
Read MorePosted by | Apr 1, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases, Molecular Diagnostics |
The kit is a real-time RT-PCR test using samples from oropharyngeal and nasopharyngeal swabs.
Read MorePosted by Steve Halasey | Mar 31, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Abbott’s new test is the fastest available molecular point-of-care test for the diagnosis of covid-19, delivering positive results in as little as 5 minutes and negative results in 13 minutes.
Read MorePosted by Steve Halasey | Mar 31, 2020 | Compliance, Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases, Lab Management |
The waiver will provide temporary relief from federal regulations requiring pathologists to render primary diagnoses onsite at healthcare facilities.
Read More